Gloria Petersen

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health
Google:
"Gloria Petersen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nguyen S, Carlson H, Yoder A, et al. (2024) Polycyclic Aromatic Hydrocarbons and Pancreatic Cancer: An Analysis of the Blood Biomarker, -1,-2,3,-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and Selected Metabolism Gene SNPs. Nutrients. 16
Chen X, Meyer MA, Kemppainen JL, et al. (2023) Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. Jama Oncology
Lindström S, Wang L, Feng H, et al. (2023) Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. Journal of the National Cancer Institute
Hogenson TL, Xie H, Phillips WJ, et al. (2022) Culture media composition influences patient-derived organoids ability to predict therapeutic response in gastrointestinal cancers. Jci Insight
Majumder S, Taylor WR, Foote PH, et al. (2022) Tissue methylated DNA markers for sporadic pancreatic cancer are strongly associated with familial and genetically predisposed pancreatic cancer. Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]
Rabe KG, Stevens MA, Hernández AT, et al. (2022) Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genetics in Medicine : Official Journal of the American College of Medical Genetics
Marcano-Bonilla L, Schleck CD, Harmsen WS, et al. (2022) Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 31: 804-810
Gits HC, Tang AH, Harmsen WS, et al. (2021) Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy. Journal of Gastrointestinal Oncology. 12: 2275-2286
Antwi SO, Rabe KG, Bamlet WR, et al. (2021) Influence of cancer susceptibility gene mutations and ABO blood group of pancreatic cancer probands on concomitant risk to first-degree relatives. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology
Blackford AL, Childs EJ, Porter N, et al. (2021) A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO. British Journal of Cancer
See more...